Eaton Vance Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $565M | Buy |
|
|||||
|
2022
Q2 | $625M | Sell |
|
|||||
|
2022
Q1 | $671M | Buy |
|
|||||
|
2021
Q4 | $516M | Sell |
|
|||||
|
2021
Q3 | $412M | Buy |
|
|||||
|
2021
Q2 | $426M | Buy |
|
|||||
|
2021
Q1 | $384M | Buy |
|
|||||
|
2020
Q4 | $321M | Sell |
|
|||||
|
2020
Q3 | $264M | Buy |
|
|||||
|
2020
Q2 | $234M | Buy |
|
|||||
|
2020
Q1 | $158M | Sell |
|
|||||
|
2019
Q4 | $209M | Sell |
|
|||||
|
2019
Q3 | $184M | Sell |
|
|||||
|
2019
Q2 | $187M | Buy |
|
|||||
|
2019
Q1 | $204M | Sell |
|
|||||
|
2018
Q4 | $267M | Sell |
|
|||||
|
2018
Q3 | $284M | Sell |
|
|||||
|
2018
Q2 | $284M | Sell |
|
|||||
|
2018
Q1 | $652M | Buy |
|
|||||
|
2017
Q4 | $329M | Buy |
|
|||||
|
2017
Q3 | $276M | Buy |
|
|||||
|
2017
Q2 | $197M | Buy |
|
|||||
|
2017
Q1 | $173M | Sell |
|
|||||
|
2016
Q4 | $191M | Buy |
|
|||||
|
2016
Q3 | $182M | Sell |
|
|||||
|
2016
Q2 | $210M | Buy |
|
|||||
|
2016
Q1 | $125M | Sell |
|
|||||
|
2015
Q4 | $136M | Sell |
|
|||||
|
2015
Q3 | $318M | Buy |
|
|||||
|
2015
Q2 | $239M | Buy |
|
|||||
|
2015
Q1 | $130M | Buy |
|
|||||
|
2014
Q4 | $139M | Sell |
|
|||||
|
2014
Q3 | $125M | Sell |
|
|||||
|
2014
Q2 | $128M | Sell |
|
|||||
|
2014
Q1 | $121M | Sell |
|
|||||
|
2013
Q4 | $127M | Sell |
|
|||||
|
2013
Q3 | $120M | Sell |
|
|||||
|
2013
Q2 | $117M | Buy |
|